the problem with this stock is, in the past 2 years there were a number of developments, many of which were truly encouraging, however the sp has been depressed every time!
the retail shareholders actually felt numb on this and lack of interest to buy into it(they know the sp will drop back after the short rise).
The management has done a poor job in term of promoting the potential of Pharmaxis.
I hope, in not far future, this company will soar suddenly.
PXS Price at posting:
27.0¢ Sentiment: Hold Disclosure: Held
